ulcerative-colitis

Documents about ulcerative-colitis

• TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS#906507ClinicalTrials.gov
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.#907440ClinicalTrials.gov
• Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis#914080ClinicalTrials.gov
• Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis#993713ClinicalTrials.gov
• Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment#849746ClinicalTrials.gov
• Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis#872445ClinicalTrials.gov
• Fulminant Ulcerative Colitis Complicated by Multiple Colonic Perforations: A Case Report#427392HAL (France)
• Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis#18573ClinicalTrials.gov
• Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.#804185ClinicalTrials.gov
• Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis#806290ClinicalTrials.gov
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease#813710ClinicalTrials.gov
• Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis#830671ClinicalTrials.gov
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis#831521ClinicalTrials.gov
• Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)#852000ClinicalTrials.gov
• Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients#856350ClinicalTrials.gov
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)#861297ClinicalTrials.gov
• A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis#874485ClinicalTrials.gov
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients#877461ClinicalTrials.gov
• Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).#905205ClinicalTrials.gov
• Using Breath Tests to Study Gut Sulfur Changes During Dietary Therapy#911335ClinicalTrials.gov
• Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)#966625ClinicalTrials.gov
• The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis#981121ClinicalTrials.gov
• Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose#992248ClinicalTrials.gov
• Wild Blueberries in Colitis#329541ClinicalTrials.gov
• Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment#881870ClinicalTrials.gov
• Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo#888145ClinicalTrials.gov
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)#828398ClinicalTrials.gov
• A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis#841833ClinicalTrials.gov
• A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis#847855ClinicalTrials.gov
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis#847884ClinicalTrials.gov
• Trial on Profermin and Fresubin in Ulcerative Colitis#882084ClinicalTrials.gov
• Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE#892942ClinicalTrials.gov
• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis#900974ClinicalTrials.gov
• The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis#907802ClinicalTrials.gov
• Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis#966549ClinicalTrials.gov
• The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative Colitis#980478ClinicalTrials.gov
• Impact of Fecal Microbiota Transplantation in Ulcerative Colitis#1030207ClinicalTrials.gov
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)#1030903ClinicalTrials.gov
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis#831742ClinicalTrials.gov
• Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis#840495ClinicalTrials.gov
• Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)#902700ClinicalTrials.gov
• Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis#903752ClinicalTrials.gov
• Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab#992360ClinicalTrials.gov
• A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis#1010577ClinicalTrials.gov
• Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）#909405ClinicalTrials.gov
• Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis#993747ClinicalTrials.gov
• A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis#837542ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)#1008681ClinicalTrials.gov
• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis#838151ClinicalTrials.gov
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)#866768ClinicalTrials.gov